Literature DB >> 15064244

Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients.

M P Margarson1, N C Soni.   

Abstract

BACKGROUND: Patients with systemic sepsis develop a capillary leak syndrome, and serum -albumin concentration decreases. Hyperoncotic albumin infusion can be used for volume expansion in these patients, but the degree and duration of effect are not well described. We assessed volume expansion by albumin 20% infusion and compared the retention of infused albumin in septic patients and healthy controls.
METHODS: We gave albumin 20%, 200 ml as a rapid infusion to 70 patients with septic shock and 26 controls. Blood samples were taken before and 1, 5, 15, 30, 60, 120 and 240 min after the infusion for measurement of serum albumin concentration and haematocrit. Haemodilution and the percentage of administered albumin remaining intravascularly at each time were calculated.
RESULTS: The mean proportion of the increase in albumin remaining at 4 h was 68.5 (sd 10)% in septic patients and 79 (5)% in controls (P<0.001). The albumin 20%, 200 ml caused a secondary fluid resorption and volume expansion maximal at 30 min, equivalent to a 430 ml infusion in septic patients and 500 ml in controls.
CONCLUSIONS: After giving albumin, serum albumin concentrations decrease significantly faster in septic patients than in healthy controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064244     DOI: 10.1093/bja/aeh111

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  19 in total

1.  Liver injury and abscess formation in secondary murine peritonitis.

Authors:  Andreas M Lenz; Mark Fairweather; James C Peyton; Sarah A Gardner; William G Cheadle
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

2.  Comment on "Changes in acid-base balance following bolus infusion of 20% albumin solution in humans" by Bruegger et al.

Authors:  Werner Lang
Journal:  Intensive Care Med       Date:  2006-02-15       Impact factor: 17.440

3.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

4.  Fluid volume kinetics of 20% albumin.

Authors:  Robert G Hahn; Markus Zdolsek; Emma Hasselgren; Joachim Zdolsek; Håkan Björne
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

5.  Small volume resuscitation with 20% albumin in intensive care: physiological effects : The SWIPE randomised clinical trial.

Authors:  Johan Mårtensson; Shailesh Bihari; Jonathan Bannard-Smith; Neil J Glassford; Patryck Lloyd-Donald; Luca Cioccari; Nora Luethi; Aiko Tanaka; Marco Crisman; Nicolas Rey de Castro; Marcus Ottochian; Agnes Huang; Maria Cronhjort; Andrew D Bersten; Shivesh Prakash; Michael Bailey; Glenn M Eastwood; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2018-10-21       Impact factor: 17.440

6.  Hyperoncotic Albumin Reduces Net Fluid Loss Associated With Hemodialysis.

Authors:  Mitchell S Buckley; Brian L Erstad; Jake M Lansburg; Sumit K Agarwal
Journal:  Hosp Pharm       Date:  2019-02-04

Review 7.  Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion.

Authors:  Christopher Valerio; Eleni Theocharidou; Andrew Davenport; Banwari Agarwal
Journal:  World J Hepatol       Date:  2016-03-08

8.  [Acute perioperative hemodilution without using hydroxyethyl starch : hemodynamic alterations under "controlled" hypovolemia].

Authors:  K Hofmann-Kiefer; D Chappell; M Jacob; A Schülke; T Helfen; J Anetzberger; M Rehm
Journal:  Anaesthesist       Date:  2014-11-09       Impact factor: 1.041

9.  Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.

Authors:  Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-07       Impact factor: 6.447

10.  Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation.

Authors:  Lukas Bruegger; Peter Studer; Stefan W Schmid; Gunther Pestel; Juerg Reichen; Christian Seiler; Daniel Candinas; Daniel Inderbitzin
Journal:  J Gastrointest Surg       Date:  2007-10-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.